Home »
A genomic analysis of lung cancer in people with no history of smoking has found that a majority of these tumors arise from the accumulation of mutations caused by natural processes in the body. This study was conducted by an international team led by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), and […]
Read more
NEW YORK (Reuters Health) – A new study confirms that delayed surgical treatment is associated with poor oncologic outcomes in patients with non-small-cell lung cancer (NSCLC). “Previously, we had a poor understanding of how delaying lung-cancer surgery may impact long-term outcomes. This became particularly relevant during the early phases of the COVID-19 pandemic,” Dr. Brendan T. Heiden of Washington University […]
Read more
In a study recently published in the leading journal "Blood", Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and the dispensary of Vienna General Hospital, provided preliminary data on the incidence, risk factors […]
Read more
In a viewpoint perspective published in JAMA on March 9, 2021, a University of North Carolina Lineberger Comprehensive Cancer Center researcher and two other experts endorsed the Center for Medicare & Medicaid Services' (CMS) requirement for a patient and their doctor to engage in a shared discussion of benefits and harms before proceeding with a low-dose spiral computed tomography (LDCT) […]
Read more
A team of Roswell Park Comprehensive Cancer Center researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors (ICI) shortly after patients with non-small cell lung cancer (NSCLC) initiate therapy. This discovery, published today in the journal Nature Communications, is not only an important step forward in lung cancer treatment, but also has implications for other […]
Read more
After 40 years of effort, researchers have finally succeeded in switching off one of the most common cancer-causing genetic mutations in the human body. The finding promises to improve treatment for thousands of patients with lung and colorectal cancer, and may point the way to a new generation of drugs for cancers that resist treatment. The finding has already led […]
Read more
Order Medicines & Health Products from Online Pharmacy for Skin, Hair, Heart and all Personal Daily Health. Baby, Men, Women & Elderly care Products Online. Buy prescription medicines, OTC products & household needs.
Read more
The pathogenesis of lung cancer is initiated the either by the activation of oncogenes or the inactivation of tumor suppressor genes, which leads to uncontrolled replication and growth of the cells in the lungs. There are several factors that may lead to these genetic mutations and they may be inherited from parents or acquired by exposure to carcinogens. Image Credit: […]
Read more
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TEVATREXED® VERSION 1.0 Pemetrexed disodium Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Pemetrexed. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in this leaflet […]
Read more
Order Medicines & Health Products from Online Pharmacy for Skin, Hair, Heart and all Personal Daily Health. Baby, Men, Women & Elderly care Products Online. Buy prescription medicines, OTC products & household needs.
Read more